Cargando…
2018 Synaptic vesicle 2 receptors as a novel targets for neuroendocrine cancer therapy
OBJECTIVES/SPECIFIC AIMS: (1) To delineate the function of the heavy-chain receptor binding domain (HCR), a portion of botulinum neurotoxin type A (BoNT/A) and synaptic vesicle 2 (SV2) signaling pathway, which provide a novel multipurpose biologic with potential clinical applications in tumor detect...
Autores principales: | Jaskula-Sztul, Renata, Whitt, Jason D., Ou, Jianfa, Liu, Margaret X., Aburjania, Zviadi, Chen, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799207/ http://dx.doi.org/10.1017/cts.2018.125 |
Ejemplares similares
-
Synthetic Makaluvamine Analogs Decrease c-Kit Expression and Are Cytotoxic to Neuroendocrine Tumor Cells
por: Aburjania, Zviadi, et al.
Publicado: (2020) -
Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates
por: Herring, Brendon, et al.
Publicado: (2021) -
Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo
por: Jang, Samuel, et al.
Publicado: (2017) -
3249 Defining the Extracellular Vesicle Content of Interstitial Fluid for Blood-Free Diagnostics; Extraction Methods and Initial Characterization
por: Robert Taylor, Justin Baca, et al.
Publicado: (2019) -
3212 Development of a Contractile Fontan Circuit to Decrease Central Venous Pressures in Single Ventricle Patients
por: Ferrari, Margaret Rose, et al.
Publicado: (2019)